Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Review Article

Orphan Drugs (Drugs Used in Rare Diseases) Situations in Turkey and in the World

Ece Doguc.

Rare diseases are defined as diseases or disorders that cause genetic origin, low incidence (life-threatening or chronic depressive, resulting in premature deaths and visible decline in the quality of life or socio-economic potential of the individual. Orphan drug; Is the term used for the treatment of rare disorders; Because the number of patients affected is so low that it is not profitable to invest or market research and development and marketing. Orphan medicines are considered the most expensive medicines in the world. Rare diseases entered the health agenda when the Orphan Drug Regulation was issued in the US in 1983. As a result of the investigations, it has been found that there are no regulations on orphan medicines in Turkey and that it is necessary to develop orphan medicines are brought from abroad by Turkish Pharmacists Association (TPA) and it is not taken into the scope of Social Security.

Key words: Nadir hastalik;yetim ilac;ilac

Share this Article

American Journal of Physiology, Biochemistry and Pharmacology


ScopeMed Home
Follow ScopeMed on Twitter
Article Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons